Yet, despite all of these limitations we observed highly significant improvement from baseline following treatment in all three medication groups after 8 weeks, these results may therefore indicate effectiveness of these anticonvulsants in the monotherapy treatment of mild to moderate dysphoric mania.
← all excerpts
Anticonvulsant treatments of dysphoric mania: a trial of gabapentin, lamotrigine and carbamazepine in Iran.
1
—
—